英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
C6H5OH查看　C6H5OH　在百度字典中的解释百度英翻中〔查看〕
C6H5OH查看　C6H5OH　在Google字典中的解释Google英翻中〔查看〕
C6H5OH查看　C6H5OH　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Huntingtons Disease (HD) Chorea Treatment - AUSTEDO XR®
    The most common side effects of AUSTEDO XR are expected to be similar to AUSTEDO in people with Huntington’s disease or tardive dyskinesia These are not all the possible side effects of AUSTEDO XR or AUSTEDO Call your doctor for medical advice about side effects You are encouraged to report side effects of prescription drugs to the FDA
  • Austedo Austedo XR: Uses, Side Effects, Dosage Guide
    Austedo XR (extended-release tablet) is taken once daily, and Austedo tablets are taken twice daily What is Tardive dyskinesia (TD) and Huntington’s disease chorea Tardive dyskinesia (TD) is a nervous system disorder that causes repetitive, uncontrolled muscle movements, usually in the face (chewing, lip smacking, frowning, tongue movement
  • AUSTEDO XR AUSTEDO DOSAGE FORMS AND STRENGTHS
    • AUSTEDO XR and AUSTEDO are contraindicated in patients who are suicidal, and in patients with untreated or inadequately treated depression (4, 5 1) INDICATIONS AND USAGE AUSTEDO XR and AUSTEDO are vesicular monoamine transporter 2 (VMAT2) inhibitors indicated in adults for the treatment of: • Chorea associated with Huntington’s
  • Austedo: Huntingtons Disease Uses, Side Effects, Dosage
    Austedo is a prescription medication that is used to treat the involuntary movements (chorea) of Huntington's disease The most common side effects of Austedo in people with tardive dyskinesia include inflammation of the nose and throat (nasopharyngitis) and problems sleeping (insomnia) Austedo can increase the risk of depression and suicidal thoughts and behavior (suicidality) in patients
  • Austedo (deutetrabenazine) for Huntington’s disease . . .
    There was also a dose-proportional exposure to Austedo XR in the blood for all pharmacokinetics parameters and over the recommended dose range (6-48 mg) Common side effects of Austedo The most common side effects associated with Austedo and Austedo XR in Huntington’s include: somnolence or sleepiness; diarrhea; dry mouth; fatigue
  • Clinical Policy: Deutetrabenazine (Austedo, Austedo XR)
    Deutetrabenazine (Austedo ®, Austedo ® XR) is a vesicular monoamine transporter 2 (VMAT2) inhibitor FDA Approved Indication(s) Austedo and Austedo XR are indicated for the treatment of: • Chorea associated with Huntington’s disease • Tardive dyskinesia (TD) in adults Policy Criteria
  • Austedo XR Approved: A New Treatment Option for Tardive . . .
    The US Food and Drug Administration (FDA) has approved Teva Pharmaceuticals’ Austedo XR (deutetrabenazine) as a once-daily pill treatment option, available in 4 new tablet strengths (30, 36, 42, 48 mg), indicated in adults for tardive dyskinesia (TD) and Huntington disease (HD) chorea control 1
  • AUSTEDO® XR: Tardive Dyskinesia and Huntingtons Chorea Treatment
    AUSTEDO® XR (deutetrabenazine) extended-release tablets is the first medication approved to treat both tardive dyskinesia and Huntington's disease chorea See safety info including Boxed Warning Teva Shared Solutions® 1-800-887-8100
  • Teva Announces FDA Approval of AUSTEDO® XR (deutetrabenazine . . .
    AUSTEDO XR AUSTEDO is the first and only vesicular monoamine transporter 2 (VMAT2) inhibitor approved by the U S Food and Drug Administration in adults for the treatment of tardive dyskinesia (TD) and for the treatment of chorea associated with Huntington’s disease (HD) AUSTEDO XR is the once-daily formulation of AUSTEDO
  • Approved Treatments for Huntingtons Disease
    Austedo and Austedo XR Available in tablets, the medications are taken orally once or twice daily, depending on the formulation Their active ingredient is similar to that of Xenazine, an older approved treatment for Huntington’s chorea, but it is designed to last longer in the body
  • Huntington’s Disease (HD) Chorea | AUSTEDO XR . . .
    Voiceover Onscreen text: INDICATIONS AND USAGE AUSTEDO® XR (deutetrabenazine) extended-release tablets and AUSTEDO® (deutetrabenazine) tablets are indicated in adults for the treatment of chorea associated with Huntington’s disease and for the treatment of tardive dyskinesia
  • Austedo (Deutetrabenazine) - Rare Disease Advisor
    Austedo ® (deutetrabenazine) and Austedo XR are oral vesicular monoamine transporter 2 (VMAT2) inhibitors that are indicated for the treatment of chorea associated with Huntington disease (HD) in adults 1 Austedo was developed by Teva and approved by the US Food and Drug Administration (FDA) in 2017





中文字典-英文字典  2005-2009